U.K. Drug Policy Committee Calls for Legalization of Medical Cannabis
A U.K. drug policy committee has called for the legalization of medical cannabis. The Advisory Committee on the Misuse of Drugs (ACMD) issued what it called “short-term advice” in acknowledging that cannabis has medicinal benefits and that doctors should be able to prescribe it for their patients.
The committee also advised that cannabis should be rescheduled under the misuse of drugs legislation. It said the change would benefit patients and allow for more scientific research. Dr. Owen Bowden-Jones, the chair of the ACMD, noted in a statement that patients with some health conditions should have access to medicinal cannabis.
“The ACMD advises that clinicians in the U.K. should have the option to prescribe Cannabis-derived medicinal products that meet the requirements for medicinal standards to patients with certain medical conditions,” Bowden-Jones said.
“It is important that clinicians, patients, and their families are confident that any prescribed medication is both safe and effective,” Bowden-Jones added.
The committee chair also said that standards for medical cannabis therapies and protocols for their use should be established by the Department of Health and Social Care (DHSC).
“The ACMD recommends that an appropriate definition be agreed by DHSC and Medicines and Healthcare Products Regulatory Authority (MHRA)